1. Home
  2. CLNN vs WKEY Comparison

CLNN vs WKEY Comparison

Compare CLNN & WKEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • WKEY
  • Stock Information
  • Founded
  • CLNN 2012
  • WKEY 1999
  • Country
  • CLNN United States
  • WKEY Switzerland
  • Employees
  • CLNN N/A
  • WKEY N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • WKEY EDP Services
  • Sector
  • CLNN Health Care
  • WKEY Technology
  • Exchange
  • CLNN Nasdaq
  • WKEY Nasdaq
  • Market Cap
  • CLNN 60.3M
  • WKEY 58.9M
  • IPO Year
  • CLNN N/A
  • WKEY N/A
  • Fundamental
  • Price
  • CLNN $9.42
  • WKEY $6.54
  • Analyst Decision
  • CLNN Strong Buy
  • WKEY Strong Buy
  • Analyst Count
  • CLNN 6
  • WKEY 2
  • Target Price
  • CLNN $32.67
  • WKEY $7.50
  • AVG Volume (30 Days)
  • CLNN 149.6K
  • WKEY 180.8K
  • Earning Date
  • CLNN 11-12-2025
  • WKEY 09-23-2025
  • Dividend Yield
  • CLNN N/A
  • WKEY N/A
  • EPS Growth
  • CLNN N/A
  • WKEY N/A
  • EPS
  • CLNN N/A
  • WKEY N/A
  • Revenue
  • CLNN $286,000.00
  • WKEY $11,994,000.00
  • Revenue This Year
  • CLNN N/A
  • WKEY $32.29
  • Revenue Next Year
  • CLNN $1,363.77
  • WKEY $89.83
  • P/E Ratio
  • CLNN N/A
  • WKEY N/A
  • Revenue Growth
  • CLNN N/A
  • WKEY N/A
  • 52 Week Low
  • CLNN $2.28
  • WKEY $1.61
  • 52 Week High
  • CLNN $11.06
  • WKEY $14.00
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 66.11
  • WKEY 55.91
  • Support Level
  • CLNN $8.54
  • WKEY $6.25
  • Resistance Level
  • CLNN $11.00
  • WKEY $7.10
  • Average True Range (ATR)
  • CLNN 0.83
  • WKEY 0.53
  • MACD
  • CLNN 0.29
  • WKEY 0.02
  • Stochastic Oscillator
  • CLNN 62.27
  • WKEY 47.37

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

Share on Social Networks: